EPISODE · Sep 16, 2022 · 47 MIN
42. Evernow founder Alicia Jackson is all-in on menopause
from The Hotflash inc podcast · host Hotflash inc
Send a textDr Alicia Jackson is an American scientist, health-tech entrepreneur and CEO and founder of Evernow — a next-generation telemedicine startup that is completely focused on menopause and provides FDA-approved treatment from specialists. Evernow also recently announced a very significant round of funding, with some very influential donors. We speak all about how Alicia went from MIT to menopause, how and why Evernow attracted A-list celebrity funding, modern menopause hormone therapy and what she sees as most important moving forward.Join the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information
What this episode covers
Send a textDr Alicia Jackson is an American scientist, health-tech entrepreneur and CEO and founder of Evernow — a next-generation telemedicine startup that is completely focused on menopause and provides FDA-approved treatment from specialists. Evernow also recently announced a very significant round of funding, with some very influential donors. We speak all about how Alicia went from MIT to menopause, how and why Evernow attracted A-list celebrity funding, modern menopause hormone therapy and what she sees as most important moving forward.Join the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information
NOW PLAYING
42. Evernow founder Alicia Jackson is all-in on menopause
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m